Global and United States Herpes Zoste Drug Market Insights, Forecast to 2026

Global and United States Herpes Zoste Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Herpes Zoste Drug Product Introduction
1.2 Market Segments
1.3 Key Herpes Zoste Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Herpes Zoste Drug Market Size Growth Rate by Type
1.4.2 Acyclovir
1.4.3 Amenamevir
1.4.4 FV-100
1.4.5 GLS-5100
1.4.6 GSK-1437173A
1.4.7 NAL-3221
1.4.8 Others
1.5 Market by Application
1.5.1 Global Herpes Zoste Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Herpes Zoste Drug Market Size, Estimates and Forecasts
2.1.1 Global Herpes Zoste Drug Revenue 2015-2026
2.1.2 Global Herpes Zoste Drug Sales 2015-2026
2.2 Global Herpes Zoste Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Herpes Zoste Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Herpes Zoste Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Herpes Zoste Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Herpes Zoste Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Herpes Zoste Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Herpes Zoste Drug Revenue Forecast by Region (2021-2026)
3 Global Herpes Zoste Drug Competitor Landscape by Players
3.1 Global Top Herpes Zoste Drug Sales by Manufacturers
3.1.1 Global Herpes Zoste Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Herpes Zoste Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Herpes Zoste Drug Manufacturers by Revenue
3.2.1 Global Herpes Zoste Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Herpes Zoste Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Herpes Zoste Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Herpes Zoste Drug Revenue in 2019
3.2.5 Global Herpes Zoste Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Herpes Zoste Drug Price by Manufacturers
3.4 Global Herpes Zoste Drug Manufacturing Base Distribution, Product Types
3.4.1 Herpes Zoste Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Herpes Zoste Drug Product Type
3.4.3 Date of International Manufacturers Enter into Herpes Zoste Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Herpes Zoste Drug Market Size by Type (2015-2020)
4.1.1 Global Herpes Zoste Drug Sales by Type (2015-2020)
4.1.2 Global Herpes Zoste Drug Revenue by Type (2015-2020)
4.1.3 Herpes Zoste Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Herpes Zoste Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Herpes Zoste Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Herpes Zoste Drug Revenue Forecast by Type (2021-2026)
4.2.3 Herpes Zoste Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Herpes Zoste Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Herpes Zoste Drug Market Size by Application (2015-2020)
5.1.1 Global Herpes Zoste Drug Sales by Application (2015-2020)
5.1.2 Global Herpes Zoste Drug Revenue by Application (2015-2020)
5.1.3 Herpes Zoste Drug Price by Application (2015-2020)
5.2 Herpes Zoste Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Herpes Zoste Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Herpes Zoste Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Herpes Zoste Drug Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Herpes Zoste Drug Market Size YoY Growth 2015-2026
6.1.1 United States Herpes Zoste Drug Sales YoY Growth 2015-2026
6.1.2 United States Herpes Zoste Drug Revenue YoY Growth 2015-2026
6.1.3 United States Herpes Zoste Drug Market Share in Global Market 2015-2026
6.2 United States Herpes Zoste Drug Market Size by Players (International and Local Players)
6.2.1 United States Top Herpes Zoste Drug Players by Sales (2015-2020)
6.2.2 United States Top Herpes Zoste Drug Players by Revenue (2015-2020)
6.3 United States Herpes Zoste Drug Historic Market Review by Type (2015-2020)
6.3.1 United States Herpes Zoste Drug Sales Market Share by Type (2015-2020)
6.3.2 United States Herpes Zoste Drug Revenue Market Share by Type (2015-2020)
6.3.3 United States Herpes Zoste Drug Price by Type (2015-2020)
6.4 United States Herpes Zoste Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Herpes Zoste Drug Sales Forecast by Type (2021-2026)
6.4.2 United States Herpes Zoste Drug Revenue Forecast by Type (2021-2026)
6.4.3 United States Herpes Zoste Drug Price Forecast by Type (2021-2026)
6.5 United States Herpes Zoste Drug Historic Market Review by Application (2015-2020)
6.5.1 United States Herpes Zoste Drug Sales Market Share by Application (2015-2020)
6.5.2 United States Herpes Zoste Drug Revenue Market Share by Application (2015-2020)
6.5.3 United States Herpes Zoste Drug Price by Application (2015-2020)
6.6 United States Herpes Zoste Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Herpes Zoste Drug Sales Forecast by Application (2021-2026)
6.6.2 United States Herpes Zoste Drug Revenue Forecast by Application (2021-2026)
6.6.3 United States Herpes Zoste Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Herpes Zoste Drug Market Size YoY Growth 2015-2026
7.2 North America Herpes Zoste Drug Market Facts & Figures by Country
7.2.1 North America Herpes Zoste Drug Sales by Country (2015-2020)
7.2.2 North America Herpes Zoste Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Herpes Zoste Drug Market Size YoY Growth 2015-2026
8.2 Europe Herpes Zoste Drug Market Facts & Figures by Country
8.2.1 Europe Herpes Zoste Drug Sales by Country
8.2.2 Europe Herpes Zoste Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Herpes Zoste Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Herpes Zoste Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Herpes Zoste Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Herpes Zoste Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Herpes Zoste Drug Market Size YoY Growth 2015-2026
10.2 Latin America Herpes Zoste Drug Market Facts & Figures by Country
10.2.1 Latin America Herpes Zoste Drug Sales by Country
10.2.2 Latin America Herpes Zoste Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Herpes Zoste Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Herpes Zoste Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Herpes Zoste Drug Sales by Country
11.2.2 Middle East and Africa Herpes Zoste Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Astellas Pharma Inc.
12.1.1 Astellas Pharma Inc. Corporation Information
12.1.2 Astellas Pharma Inc. Description and Business Overview
12.1.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Astellas Pharma Inc. Herpes Zoste Drug Products Offered
12.1.5 Astellas Pharma Inc. Recent Development
12.2 Beijing Minhai Biotechnology Co., Ltd
12.2.1 Beijing Minhai Biotechnology Co., Ltd Corporation Information
12.2.2 Beijing Minhai Biotechnology Co., Ltd Description and Business Overview
12.2.3 Beijing Minhai Biotechnology Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Products Offered
12.2.5 Beijing Minhai Biotechnology Co., Ltd Recent Development
12.3 ContraVir Pharmaceuticals, Inc.
12.3.1 ContraVir Pharmaceuticals, Inc. Corporation Information
12.3.2 ContraVir Pharmaceuticals, Inc. Description and Business Overview
12.3.3 ContraVir Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.3.4 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Products Offered
12.3.5 ContraVir Pharmaceuticals, Inc. Recent Development
12.4 Epiphany Biosciences, Inc.
12.4.1 Epiphany Biosciences, Inc. Corporation Information
12.4.2 Epiphany Biosciences, Inc. Description and Business Overview
12.4.3 Epiphany Biosciences, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Epiphany Biosciences, Inc. Herpes Zoste Drug Products Offered
12.4.5 Epiphany Biosciences, Inc. Recent Development
12.5 Foamix Pharmaceuticals Ltd.
12.5.1 Foamix Pharmaceuticals Ltd. Corporation Information
12.5.2 Foamix Pharmaceuticals Ltd. Description and Business Overview
12.5.3 Foamix Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Products Offered
12.5.5 Foamix Pharmaceuticals Ltd. Recent Development
12.6 GeneOne Life Science, Inc.
12.6.1 GeneOne Life Science, Inc. Corporation Information
12.6.2 GeneOne Life Science, Inc. Description and Business Overview
12.6.3 GeneOne Life Science, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.6.4 GeneOne Life Science, Inc. Herpes Zoste Drug Products Offered
12.6.5 GeneOne Life Science, Inc. Recent Development
12.7 GlaxoSmithKline Plc
12.7.1 GlaxoSmithKline Plc Corporation Information
12.7.2 GlaxoSmithKline Plc Description and Business Overview
12.7.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GlaxoSmithKline Plc Herpes Zoste Drug Products Offered
12.7.5 GlaxoSmithKline Plc Recent Development
12.8 Merck & Co., Inc.
12.8.1 Merck & Co., Inc. Corporation Information
12.8.2 Merck & Co., Inc. Description and Business Overview
12.8.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Merck & Co., Inc. Herpes Zoste Drug Products Offered
12.8.5 Merck & Co., Inc. Recent Development
12.9 NAL Pharmaceuticals Ltd.
12.9.1 NAL Pharmaceuticals Ltd. Corporation Information
12.9.2 NAL Pharmaceuticals Ltd. Description and Business Overview
12.9.3 NAL Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Products Offered
12.9.5 NAL Pharmaceuticals Ltd. Recent Development
12.10 ReceptoPharm, Inc.
12.10.1 ReceptoPharm, Inc. Corporation Information
12.10.2 ReceptoPharm, Inc. Description and Business Overview
12.10.3 ReceptoPharm, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.10.4 ReceptoPharm, Inc. Herpes Zoste Drug Products Offered
12.10.5 ReceptoPharm, Inc. Recent Development
12.11 Astellas Pharma Inc.
12.11.1 Astellas Pharma Inc. Corporation Information
12.11.2 Astellas Pharma Inc. Description and Business Overview
12.11.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Astellas Pharma Inc. Herpes Zoste Drug Products Offered
12.11.5 Astellas Pharma Inc. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Herpes Zoste Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Herpes Zoste Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Herpes Zoste Drug Market Segments
Table 2. Ranking of Global Top Herpes Zoste Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Herpes Zoste Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Acyclovir
Table 5. Major Manufacturers of Amenamevir
Table 6. Major Manufacturers of FV-100
Table 7. Major Manufacturers of GLS-5100
Table 8. Major Manufacturers of GSK-1437173A
Table 9. Major Manufacturers of NAL-3221
Table 10. Major Manufacturers of Others
Table 11. Global Herpes Zoste Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Herpes Zoste Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Herpes Zoste Drug Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Herpes Zoste Drug Sales Market Share by Regions (2015-2020)
Table 15. Global Herpes Zoste Drug Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Herpes Zoste Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 17. Global Herpes Zoste Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 18. Global Herpes Zoste Drug Sales Share by Manufacturers (2015-2020)
Table 19. Global Herpes Zoste Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Herpes Zoste Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Zoste Drug as of 2019)
Table 21. Herpes Zoste Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Herpes Zoste Drug Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Herpes Zoste Drug Price (2015-2020) (USD/Pcs)
Table 24. Herpes Zoste Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Herpes Zoste Drug Product Type
Table 26. Date of International Manufacturers Enter into Herpes Zoste Drug Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Herpes Zoste Drug Sales by Type (2015-2020) (K Pcs)
Table 29. Global Herpes Zoste Drug Sales Share by Type (2015-2020)
Table 30. Global Herpes Zoste Drug Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Herpes Zoste Drug Revenue Share by Type (2015-2020)
Table 32. Herpes Zoste Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 33. Global Herpes Zoste Drug Sales Share by Type (2021-2026)
Table 34. Global Herpes Zoste Drug Sales by Application (2015-2020) (K Pcs)
Table 35. Global Herpes Zoste Drug Sales Share by Application (2015-2020)
Table 36. Global Herpes Zoste Drug Sales Share by Application (2021-2026)
Table 37. Global Herpes Zoste Drug Sales Market Share Forecast by Application (2021-2026)
Table 38. Global Herpes Zoste Drug Revenue by Application (2015-2020) (US$ Million)
Table 39. Global Herpes Zoste Drug Revenue Market Share Forecast by Application (2021-2026)
Table 40. United States Herpes Zoste Drug Sales (K Pcs) of Key Companies (2015-2020)
Table 41. United States Herpes Zoste Drug Sales Share by Company (2015-2020)
Table 42. United States Herpes Zoste Drug Revenue (US$ Million) by Company (2015-2020)
Table 43. United States Herpes Zoste Drug Sales (K Pcs) by Type (2015-2020)
Table 44. United States Herpes Zoste Drug Sales Share by Type (2015-2020)
Table 45. United States Herpes Zoste Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 46. United States Herpes Zoste Drug Price (K Pcs) by Type (2015-2020)
Table 47. United States Herpes Zoste Drug Sales (K Pcs) by Type (2021-2026)
Table 48. United States Herpes Zoste Drug Sales Share by Type (2021-2026)
Table 49. United States Herpes Zoste Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 50. United States Herpes Zoste Drug Revenue Share by Type (2021-2026)
Table 51. United States Herpes Zoste Drug Price (K Pcs) by Type (2021-2026)
Table 52. United States Herpes Zoste Drug Sales (K Pcs) by Application (2015-2020)
Table 53. United States Herpes Zoste Drug Sales Share by Application (2015-2020)
Table 54. United States Herpes Zoste Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 55. United States Herpes Zoste Drug Sales (K Pcs) by Application (2021-2026)
Table 56. United States Herpes Zoste Drug Sales Share by Application (2021-2026)
Table 57. United States Herpes Zoste Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 58. United States Herpes Zoste Drug Revenue Share by Application (2021-2026)
Table 59. North America Herpes Zoste Drug Sales by Country (2015-2020) (K Pcs)
Table 60. North America Herpes Zoste Drug Sales Market Share by Country (2015-2020)
Table 61. North America Herpes Zoste Drug Revenue by Country (2015-2020) (US$ Million)
Table 62. North America Herpes Zoste Drug Revenue Market Share by Country (2015-2020)
Table 63. Europe Herpes Zoste Drug Sales by Country (2015-2020) (K Pcs)
Table 64. Europe Herpes Zoste Drug Sales Market Share by Country (2015-2020)
Table 65. Europe Herpes Zoste Drug Revenue by Country (2015-2020) (US$ Million)
Table 66. Europe Herpes Zoste Drug Revenue Market Share by Country (2015-2020)
Table 67. Asia Pacific Herpes Zoste Drug Sales by Region (2015-2020) (K Pcs)
Table 68. Asia Pacific Herpes Zoste Drug Sales Market Share by Region (2015-2020)
Table 69. Asia Pacific Herpes Zoste Drug Revenue by Region (2015-2020) (US$ Million)
Table 70. Asia Pacific Herpes Zoste Drug Revenue Market Share by Region (2015-2020)
Table 71. Latin America Herpes Zoste Drug Sales by Country (2015-2020) (K Pcs)
Table 72. Latin America Herpes Zoste Drug Sales Market Share by Country (2015-2020)
Table 73. Latin Americaa Herpes Zoste Drug Revenue by Country (2015-2020) (US$ Million)
Table 74. Latin America Herpes Zoste Drug Revenue Market Share by Country (2015-2020)
Table 75. Middle East and Africa Herpes Zoste Drug Sales by Country (2015-2020) (K Pcs)
Table 76. Middle East and Africa Herpes Zoste Drug Sales Market Share by Country (2015-2020)
Table 77. Middle East and Africa Herpes Zoste Drug Revenue by Country (2015-2020) (US$ Million)
Table 78. Middle East and Africa Herpes Zoste Drug Revenue Market Share by Country (2015-2020)
Table 79. Astellas Pharma Inc. Corporation Information
Table 80. Astellas Pharma Inc. Description and Business Overview
Table 81. Astellas Pharma Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Astellas Pharma Inc. Herpes Zoste Drug Product
Table 83. Astellas Pharma Inc. Recent Development
Table 84. Beijing Minhai Biotechnology Co., Ltd Corporation Information
Table 85. Beijing Minhai Biotechnology Co., Ltd Description and Business Overview
Table 86. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Beijing Minhai Biotechnology Co., Ltd Product
Table 88. Beijing Minhai Biotechnology Co., Ltd Recent Development
Table 89. ContraVir Pharmaceuticals, Inc. Corporation Information
Table 90. ContraVir Pharmaceuticals, Inc. Description and Business Overview
Table 91. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. ContraVir Pharmaceuticals, Inc. Product
Table 93. ContraVir Pharmaceuticals, Inc. Recent Development
Table 94. Epiphany Biosciences, Inc. Corporation Information
Table 95. Epiphany Biosciences, Inc. Description and Business Overview
Table 96. Epiphany Biosciences, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Epiphany Biosciences, Inc. Product
Table 98. Epiphany Biosciences, Inc. Recent Development
Table 99. Foamix Pharmaceuticals Ltd. Corporation Information
Table 100. Foamix Pharmaceuticals Ltd. Description and Business Overview
Table 101. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Foamix Pharmaceuticals Ltd. Product
Table 103. Foamix Pharmaceuticals Ltd. Recent Development
Table 104. GeneOne Life Science, Inc. Corporation Information
Table 105. GeneOne Life Science, Inc. Description and Business Overview
Table 106. GeneOne Life Science, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. GeneOne Life Science, Inc. Product
Table 108. GeneOne Life Science, Inc. Recent Development
Table 109. GlaxoSmithKline Plc Corporation Information
Table 110. GlaxoSmithKline Plc Description and Business Overview
Table 111. GlaxoSmithKline Plc Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. GlaxoSmithKline Plc Product
Table 113. GlaxoSmithKline Plc Recent Development
Table 114. Merck & Co., Inc. Corporation Information
Table 115. Merck & Co., Inc. Description and Business Overview
Table 116. Merck & Co., Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Merck & Co., Inc. Product
Table 118. Merck & Co., Inc. Recent Development
Table 119. NAL Pharmaceuticals Ltd. Corporation Information
Table 120. NAL Pharmaceuticals Ltd. Description and Business Overview
Table 121. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. NAL Pharmaceuticals Ltd. Product
Table 123. NAL Pharmaceuticals Ltd. Recent Development
Table 124. ReceptoPharm, Inc. Corporation Information
Table 125. ReceptoPharm, Inc. Description and Business Overview
Table 126. ReceptoPharm, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. ReceptoPharm, Inc. Product
Table 128. ReceptoPharm, Inc. Recent Development
Table 129. TSRL, Inc. Corporation Information
Table 130. TSRL, Inc. Description and Business Overview
Table 131. TSRL, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. TSRL, Inc. Product
Table 133. TSRL, Inc. Recent Development
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Herpes Zoste Drug Players
Table 138. Herpes Zoste Drug Customers List
Table 139. Herpes Zoste Drug Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Herpes Zoste Drug Product Picture
Figure 2. Global Herpes Zoste Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Acyclovir Product Picture
Figure 4. Amenamevir Product Picture
Figure 5. FV-100 Product Picture
Figure 6. GLS-5100 Product Picture
Figure 7. GSK-1437173A Product Picture
Figure 8. NAL-3221 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Herpes Zoste Drug Sales Market Share by Application in 2020 & 2026
Figure 11. Clinic
Figure 12. Hospital
Figure 13. Others
Figure 14. Herpes Zoste Drug Report Years Considered
Figure 15. Global Herpes Zoste Drug Market Size 2015-2026 (US$ Million)
Figure 16. Global Herpes Zoste Drug Sales 2015-2026 (K Pcs)
Figure 17. Global Herpes Zoste Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Herpes Zoste Drug Sales Market Share by Region (2015-2020)
Figure 19. Global Herpes Zoste Drug Sales Market Share by Region in 2019
Figure 20. Global Herpes Zoste Drug Revenue Market Share by Region (2015-2020)
Figure 21. Global Herpes Zoste Drug Revenue Market Share by Region in 2019
Figure 22. Global Herpes Zoste Drug Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Herpes Zoste Drug Revenue in 2019
Figure 24. Herpes Zoste Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Herpes Zoste Drug Sales Market Share by Type (2015-2020)
Figure 26. Global Herpes Zoste Drug Sales Market Share by Type in 2019
Figure 27. Global Herpes Zoste Drug Revenue Market Share by Type (2015-2020)
Figure 28. Global Herpes Zoste Drug Revenue Market Share by Type in 2019
Figure 29. Global Herpes Zoste Drug Market Share by Price Range (2015-2020)
Figure 30. Global Herpes Zoste Drug Sales Market Share by Application (2015-2020)
Figure 31. Global Herpes Zoste Drug Sales Market Share by Application in 2019
Figure 32. Global Herpes Zoste Drug Revenue Market Share by Application (2015-2020)
Figure 33. Global Herpes Zoste Drug Revenue Market Share by Application in 2019
Figure 34. United States Herpes Zoste Drug Sales Growth Rate 2015-2026 (K Pcs)
Figure 35. United States Herpes Zoste Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 36. United States Herpes Zoste Drug Market Share in Global Market 2015-2026
Figure 37. United States 5 and 10 Largest Herpes Zoste Drug Players Market Share by Revenue in Herpes Zoste Drug in 2019
Figure 38. United States Herpes Zoste Drug Revenue Share by Type (2015-2020)
Figure 39. United States Herpes Zoste Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 40. United States Herpes Zoste Drug Revenue Share by Application (2015-2020)
Figure 41. United States Herpes Zoste Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 42. North America Herpes Zoste Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. North America Herpes Zoste Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. North America Herpes Zoste Drug Sales Market Share by Country in 2019
Figure 45. North America Herpes Zoste Drug Revenue Market Share by Country in 2019
Figure 46. U.S. Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. U.S. Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Canada Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Canada Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Europe Herpes Zoste Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 51. Europe Herpes Zoste Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 52. Europe Herpes Zoste Drug Sales Market Share by Country in 2019
Figure 53. Europe Herpes Zoste Drug Revenue Market Share by Country in 2019
Figure 54. Germany Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Germany Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. France Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. France Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. U.K. Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. U.K. Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Italy Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Russia Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Asia Pacific Herpes Zoste Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 65. Asia Pacific Herpes Zoste Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific Herpes Zoste Drug Sales Market Share by Region in 2019
Figure 67. Asia Pacific Herpes Zoste Drug Revenue Market Share by Region in 2019
Figure 68. China Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. China Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Japan Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. South Korea Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. India Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. India Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Australia Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Australia Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Taiwan Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Taiwan Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Indonesia Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Indonesia Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Thailand Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Thailand Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Malaysia Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Malaysia Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Philippines Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Philippines Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Vietnam Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Vietnam Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Latin America Herpes Zoste Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 91. Latin America Herpes Zoste Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Herpes Zoste Drug Sales Market Share by Country in 2019
Figure 93. Latin America Herpes Zoste Drug Revenue Market Share by Country in 2019
Figure 94. Mexico Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Mexico Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Brazil Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 99. Argentina Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Middle East and Africa Herpes Zoste Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Herpes Zoste Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Herpes Zoste Drug Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Herpes Zoste Drug Revenue Market Share by Country in 2019
Figure 104. Turkey Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Herpes Zoste Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Herpes Zoste Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Porter's Five Forces Analysis
Figure 111. Herpes Zoste Drug Value Chain
Figure 112. Channels of Distribution
Figure 113. Distributors Profiles
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs